Lyn-IN-1
Lyn-IN-1, an analog of Bafetinib, is a potent and selective dual kinase inhibitor targeting both Bcr-Abl and Lyn. It is utilized in biochemical and cellular research, particularly in studies of chronic myeloid leukemia (CML), demonstrating activity in both in vitro assays and in vivo models.
Product Specifications
CAS Number
887650-05-7
Product Name Alternative
Bcr-Abl, BcrAbl, Bafetinib, Bafetinib analog, LynIN1, Lyn-IN-1, Lyn IN 1, Lyn, Inhibitor, inhibit
Field of Research
Cardiovascular Research, Signal Transduction
Purity
97.00% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.47 mM) ; DMSO:45 mg/mL (78.04 mM)
Smiles
CN (C) [C@H]1CCN (Cc2ccc (cc2C (F) (F) F) C (=O) Nc2ccc (C) c (Nc3ncc (cn3) -c3cncnc3) c2) C1
Molecular Formula
C30H31F3N8O
Molecular Weight
576.62
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-428187-LAC-2 200 µL
1600016N20Rik Lentiviral Activation Particles (m2)
Sign In for Pricing
View Details MBS6201384-01 0.1 mL
IL18R1 (Interleukin 18 Receptor 1, IL-18R-1, IL-18R1, CD218 Antigen-like Family Member A, CDw218a, IL1 Receptor-related Protein, IL-1Rrp, IL1R-rp, CD218a, IL1RRP) (MaxLight 490)
Sign In for Pricing
View Details MBS6201384-02 5x 0.1 mL
IL18R1 (Interleukin 18 Receptor 1, IL-18R-1, IL-18R1, CD218 Antigen-like Family Member A, CDw218a, IL1 Receptor-related Protein, IL-1Rrp, IL1R-rp, CD218a, IL1RRP) (MaxLight 490)
Sign In for Pricing
View Details